- Report
- May 2024
- 182 Pages
Global
From €3243EUR$3,374USD£2,742GBP
€3603EUR$3,749USD£3,047GBP
- Report
- March 2024
- 180 Pages
Global
From €3243EUR$3,374USD£2,742GBP
€3603EUR$3,749USD£3,047GBP
- Report
- March 2024
- 199 Pages
Global
From €3243EUR$3,374USD£2,742GBP
€3603EUR$3,749USD£3,047GBP
- Report
- March 2024
- 197 Pages
Global
From €3243EUR$3,374USD£2,742GBP
€3603EUR$3,749USD£3,047GBP
- Report
- May 2024
- 204 Pages
Global
From €5238EUR$5,450USD£4,429GBP
- Report
- May 2024
- 173 Pages
Global
From €4758EUR$4,950USD£4,023GBP
- Report
- March 2024
- 146 Pages
Global
From €2882EUR$2,999USD£2,437GBP
- Report
- March 2024
- 139 Pages
Global
From €3747EUR$3,899USD£3,169GBP
- Report
- February 2024
- 175 Pages
Global
From €3845EUR$4,000USD£3,251GBP
- Report
- February 2024
- 175 Pages
Global
From €4806EUR$5,000USD£4,064GBP
- Report
- April 2024
- 175 Pages
Global
From €4806EUR$5,000USD£4,064GBP
- Report
- February 2024
- 250 Pages
Global
From €4806EUR$5,000USD£4,064GBP
- Report
- November 2023
- 250 Pages
Global
From €4806EUR$5,000USD£4,064GBP
- Report
- November 2023
- 250 Pages
Global
From €4806EUR$5,000USD£4,064GBP
- Report
- February 2024
- 187 Pages
Global
From €4710EUR$4,900USD£3,982GBP
- Report
- January 2024
- 182 Pages
Global
From €4710EUR$4,900USD£3,982GBP
- Report
- October 2023
- 250 Pages
Global
From €3061EUR$3,185USD£2,589GBP
€4373EUR$4,550USD£3,698GBP
- Report
- August 2023
- 205 Pages
Global
From €3061EUR$3,185USD£2,589GBP
€4373EUR$4,550USD£3,698GBP
- Report
- February 2024
- 145 Pages
Global
From €4085EUR$4,250USD£3,454GBP
- Report
- January 2024
- 200 Pages
Global
From €3989EUR$4,150USD£3,373GBP
Hemostasis is a process that helps to stop bleeding and is a part of the larger coagulation and hemostasis testing market. This market includes products and services used to diagnose and monitor bleeding and clotting disorders. Tests used in this market include prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin time (TT), fibrinogen, and platelet aggregation. These tests are used to diagnose and monitor conditions such as hemophilia, thrombocytopenia, and von Willebrand disease.
The coagulation and hemostasis testing market is driven by the increasing prevalence of bleeding and clotting disorders, the growing demand for point-of-care testing, and the development of new technologies. Companies in this market include Siemens Healthineers, Roche Diagnostics, Abbott Laboratories, Sysmex Corporation, and Alere Inc. Show Less Read more